Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Puma Biotechnology, Inc. (PBYI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Puma Biotechnology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1401667.
Total stock buying since 2014: $2,483.
Total stock sales since 2014: $172,941,827.
Total stock option exercises since 2014: $429,400.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 245,309 | $826,302 | 0 | $0 |
| 2024 | 0 | $0 | 273,274 | $1,024,267 | 0 | $0 |
| 2023 | 0 | $0 | 237,177 | $789,148 | 0 | $0 |
| 2022 | 0 | $0 | 241,700 | $681,226 | 0 | $0 |
| 2021 | 0 | $0 | 143,738 | $1,486,673 | 0 | $0 |
| 2020 | 0 | $0 | 73,582 | $715,682 | 0 | $0 |
| 2019 | 0 | $0 | 44,904 | $781,661 | 0 | $0 |
| 2018 | 0 | $0 | 34,334 | $2,364,668 | 0 | $0 |
| 2017 | 0 | $0 | 2,065,141 | $163,942,116 | 35,000 | $395,500 |
| 2015 | 0 | $0 | 3,000 | $330,084 | 3,000 | $33,900 |
| 2014 | 30 | $2,483 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 91,511 | $318,882 | 0 | $0 |
| 2025-06 | 0 | $0 | 91,660 | $311,563 | 0 | $0 |
| 2025-01 | 0 | $0 | 62,138 | $195,857 | 0 | $0 |
| 2024-08 | 0 | $0 | 23,358 | $81,472 | 0 | $0 |
| 2024-07 | 0 | $0 | 66,891 | $232,621 | 0 | $0 |
| 2024-06 | 0 | $0 | 96,900 | $323,820 | 0 | $0 |
| 2024-01 | 0 | $0 | 86,125 | $386,354 | 0 | $0 |
| 2023-12 | 0 | $0 | 280 | $1,053 | 0 | $0 |
| 2023-11 | 0 | $0 | 25,000 | $70,800 | 0 | $0 |
| 2023-07 | 0 | $0 | 102,228 | $338,475 | 0 | $0 |
| 2023-06 | 0 | $0 | 109,669 | $378,820 | 0 | $0 |
| 2022-11 | 0 | $0 | 1,834 | $4,125 | 0 | $0 |
| 2022-10 | 0 | $0 | 1,860 | $4,342 | 0 | $0 |
| 2022-08 | 0 | $0 | 26,837 | $94,107 | 0 | $0 |
| 2022-07 | 0 | $0 | 44,483 | $117,076 | 0 | $0 |
| 2022-06 | 0 | $0 | 93,940 | $245,146 | 0 | $0 |
| 2022-05 | 0 | $0 | 2,526 | $5,871 | 0 | $0 |
| 2022-04 | 0 | $0 | 1,817 | $5,592 | 0 | $0 |
| 2022-03 | 0 | $0 | 27,562 | $76,112 | 0 | $0 |
| 2022-02 | 0 | $0 | 2,048 | $5,048 | 0 | $0 |
| 2022-01 | 0 | $0 | 38,793 | $123,807 | 0 | $0 |
| 2021-12 | 0 | $0 | 3,571 | $10,376 | 0 | $0 |
| 2021-11 | 0 | $0 | 2,378 | $13,403 | 0 | $0 |
| 2021-10 | 0 | $0 | 2,462 | $15,157 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-18 | Cesano Alessandra (Director) | Sale | 27,000 | 3.37 | 90,909 |
| 2025-07-09 | Nougues Maximo F (Chief Financial Officer) | Sale | 3,935 | 3.54 | 13,910 |
| 2025-07-09 | Hunt Douglas M (See Remarks) | Sale | 3,443 | 3.54 | 12,171 |
| 2025-07-09 | Auerbach Alan H (President and CEO) | Sale | 21,580 | 3.54 | 76,285 |
| 2025-07-08 | Nougues Maximo F (Chief Financial Officer) | Sale | 5,587 | 3.53 | 19,738 |
| 2025-07-08 | Hunt Douglas M (See Remarks) | Sale | 4,374 | 3.53 | 15,453 |
| 2025-07-08 | Auerbach Alan H (President and CEO) | Sale | 25,592 | 3.53 | 90,416 |
| 2025-06-13 | Cesano Alessandra (Director) | Sale | 12,150 | 3.40 | 41,310 |
| 2025-06-13 | Stuglik Brian M (Director) | Sale | 8,100 | 3.39 | 27,459 |
| 2025-06-13 | Dorval Allison (Director) | Sale | 11,610 | 3.40 | 39,474 |
| 2025-06-13 | Senderowicz Adrian (Director) | Sale | 27,000 | 3.40 | 91,800 |
| 2025-06-13 | Wilson Troy Edward (Director) | Sale | 10,800 | 3.40 | 36,720 |
| 2025-06-13 | Moyes Jay M (Director) | Sale | 22,000 | 3.40 | 74,800 |
| 2025-01-02 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 9,437 | 3.15 | 29,745 |
| 2025-01-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 10,227 | 3.15 | 32,235 |
| 2025-01-02 | Hunt Douglas M (See Remarks) | Sale | 8,633 | 3.15 | 27,211 |
| 2025-01-02 | Auerbach Alan H (President and CEO) | Sale | 33,841 | 3.15 | 106,666 |
| 2024-08-12 | Miller Michael Patrick (Director) | Sale | 23,358 | 3.49 | 81,472 |
| 2024-07-17 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 2,598 | 3.70 | 9,615 |
| 2024-07-17 | Nougues Maximo F (Chief Financial Officer) | Sale | 4,156 | 3.70 | 15,381 |
| 2024-07-17 | Hunt Douglas M (See Remarks) | Sale | 3,637 | 3.70 | 13,460 |
| 2024-07-17 | Auerbach Alan H (President and CEO) | Sale | 21,920 | 3.70 | 81,125 |
| 2024-07-02 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 6,051 | 3.27 | 19,780 |
| 2024-07-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 5,295 | 3.27 | 17,309 |
| 2024-07-02 | Hunt Douglas M (See Remarks) | Sale | 4,349 | 3.27 | 14,216 |
| 2024-07-02 | Auerbach Alan H (President and CEO) | Sale | 18,885 | 3.27 | 61,735 |
| 2024-06-13 | Stuglik Brian M (Director) | Sale | 9,900 | 3.39 | 33,531 |
| 2024-06-13 | Dorval Allison (Director) | Sale | 11,000 | 3.37 | 37,092 |
| 2024-06-13 | Senderowicz Adrian (Director) | Sale | 27,000 | 3.33 | 89,829 |
| 2024-06-13 | Wilson Troy Edward (Director) | Sale | 27,000 | 3.33 | 89,910 |
| 2024-06-13 | Moyes Jay M (Director) | Sale | 22,000 | 3.34 | 73,458 |
| 2024-01-03 | Wong Alvin F (Chief Scientific Officer) | Sale | 7,733 | 4.49 | 34,690 |
| 2024-01-03 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 12,956 | 4.49 | 58,120 |
| 2024-01-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 15,682 | 4.49 | 70,349 |
| 2024-01-03 | Hunt Douglas M (See Remarks) | Sale | 8,358 | 4.49 | 37,493 |
| 2024-01-03 | Auerbach Alan H (President and CEO) | Sale | 41,396 | 4.49 | 185,702 |
| 2023-12-04 | Wong Alvin F (Chief Scientific Officer) | Sale | 280 | 3.76 | 1,053 |
| 2023-11-07 | Miller Michael Patrick (Director) | Sale | 25,000 | 2.83 | 70,800 |
| 2023-07-03 | Wong Alvin F (Chief Scientific Officer) | Sale | 6,938 | 3.31 | 22,971 |
| 2023-07-03 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 12,103 | 3.31 | 40,073 |
| 2023-07-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 14,680 | 3.31 | 48,605 |
| 2023-07-03 | Hunt Douglas M (See Remarks) | Sale | 7,809 | 3.31 | 25,855 |
| 2023-07-03 | Auerbach Alan H (President and CEO) | Sale | 60,698 | 3.31 | 200,971 |
| 2023-06-13 | Stuglik Brian M (Director) | Sale | 9,900 | 3.46 | 34,254 |
| 2023-06-13 | Dorval Allison (Director) | Sale | 10,000 | 3.45 | 34,500 |
| 2023-06-13 | Senderowicz Adrian (Director) | Sale | 27,000 | 3.46 | 93,285 |
| 2023-06-13 | Wilson Troy Edward (Director) | Sale | 27,000 | 3.45 | 93,258 |
| 2023-06-13 | Miller Michael Patrick (Director) | Sale | 13,500 | 3.45 | 46,629 |
| 2023-06-13 | Moyes Jay M (Director) | Sale | 22,000 | 3.45 | 75,966 |
| 2023-06-02 | Wong Alvin F (Chief Scientific Officer) | Sale | 269 | 3.45 | 928 |
| 2022-11-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 163 | 2.25 | 366 |
| 2022-11-02 | Hunt Douglas M (See Remarks) | Sale | 429 | 2.25 | 965 |
| 2022-11-02 | Auerbach Alan H (President and CEO) | Sale | 1,242 | 2.25 | 2,794 |
| 2022-10-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 165 | 2.33 | 385 |
| 2022-10-03 | Hunt Douglas M (See Remarks) | Sale | 435 | 2.33 | 1,015 |
| 2022-10-03 | Auerbach Alan H (President and CEO) | Sale | 1,260 | 2.33 | 2,942 |
| 2022-08-09 | Miller Michael Patrick (Director) | Sale | 25,000 | 3.55 | 88,800 |
| 2022-08-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 161 | 2.89 | 465 |
| 2022-08-02 | Hunt Douglas M (See Remarks) | Sale | 429 | 2.89 | 1,239 |
| 2022-08-02 | Auerbach Alan H (President and CEO) | Sale | 1,247 | 2.89 | 3,603 |
| 2022-07-05 | Wong Alvin F (Chief Scientific Officer) | Sale | 2,920 | 2.63 | 7,685 |
| 2022-07-05 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 5,835 | 2.63 | 15,357 |
| 2022-07-05 | Nougues Maximo F (Chief Financial Officer) | Sale | 5,835 | 2.63 | 15,357 |
| 2022-07-05 | Hunt Douglas M (See Remarks) | Sale | 3,753 | 2.63 | 9,877 |
| 2022-07-05 | Auerbach Alan H (President and CEO) | Sale | 26,140 | 2.63 | 68,800 |
| 2022-06-16 | Stuglik Brian M (Director) | Sale | 13,000 | 2.69 | 34,918 |
| 2022-06-16 | Senderowicz Adrian (Director) | Sale | 27,858 | 2.63 | 73,294 |
| 2022-06-16 | Wilson Troy Edward (Director) | Sale | 27,858 | 2.58 | 71,985 |
| 2022-06-16 | Moyes Jay M (Director) | Sale | 22,858 | 2.64 | 60,367 |
| 2022-06-02 | Wong Alvin F (Chief Scientific Officer) | Sale | 587 | 1.92 | 1,129 |
| 2022-06-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 162 | 1.92 | 311 |
| 2022-06-02 | Hunt Douglas M (See Remarks) | Sale | 417 | 1.94 | 810 |
| 2022-06-02 | Auerbach Alan H (President and CEO) | Sale | 1,200 | 1.94 | 2,332 |
| 2022-05-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 495 | 2.34 | 1,158 |
| 2022-05-03 | Hunt Douglas M (See Remarks) | Sale | 438 | 2.31 | 1,011 |
| 2022-05-03 | Auerbach Alan H (President and CEO) | Sale | 1,263 | 2.32 | 2,930 |
| 2022-04-04 | Nougues Maximo F (Chief Financial Officer) | Sale | 206 | 3.08 | 634 |
| 2022-04-04 | Hunt Douglas M (See Remarks) | Sale | 413 | 3.08 | 1,271 |
| 2022-04-04 | Auerbach Alan H (President and CEO) | Sale | 1,198 | 3.08 | 3,687 |
| 2022-03-16 | Miller Michael Patrick (Director) | Sale | 25,653 | 2.80 | 71,802 |
| 2022-03-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 169 | 2.26 | 382 |
| 2022-03-02 | Hunt Douglas M (See Remarks) | Sale | 446 | 2.26 | 1,009 |
| 2022-03-02 | Auerbach Alan H (President and CEO) | Sale | 1,294 | 2.26 | 2,919 |
| 2022-02-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 199 | 2.48 | 493 |
| 2022-02-02 | Hunt Douglas M (See Remarks) | Sale | 533 | 2.47 | 1,317 |
| 2022-02-02 | Auerbach Alan H (President and CEO) | Sale | 1,316 | 2.46 | 3,238 |
| 2022-01-03 | Ludwig Jeffrey Jerome (Chief Commercial Officer) | Sale | 4,727 | 3.20 | 15,121 |
| 2022-01-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 7,484 | 3.19 | 23,873 |
| 2022-01-03 | Hunt Douglas M (See Remarks) | Sale | 3,707 | 3.21 | 11,888 |
| 2022-01-03 | Auerbach Alan H (President and CEO) | Sale | 22,875 | 3.19 | 72,925 |
| 2021-12-02 | Wong Alvin F (Chief Scientific Officer) | Sale | 1,131 | 2.91 | 3,294 |
| 2021-12-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 162 | 2.95 | 477 |
| 2021-12-02 | Hunt Douglas M (See Remarks) | Sale | 441 | 2.90 | 1,278 |
| 2021-12-02 | Auerbach Alan H (President and CEO) | Sale | 1,837 | 2.90 | 5,327 |
| 2021-11-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 156 | 5.67 | 884 |
| 2021-11-02 | Hunt Douglas M (See Remarks) | Sale | 427 | 5.64 | 2,408 |
| 2021-11-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,795 | 5.63 | 10,111 |
| 2021-10-04 | Nougues Maximo F (Chief Financial Officer) | Sale | 161 | 6.20 | 998 |
| 2021-10-04 | Hunt Douglas M (See Remarks) | Sale | 443 | 6.15 | 2,725 |
| 2021-10-04 | Auerbach Alan H (President and CEO) | Sale | 1,858 | 6.15 | 11,434 |
| 2021-09-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 155 | 7.51 | 1,164 |
| 2021-09-02 | Hunt Douglas M (See Remarks) | Sale | 422 | 7.52 | 3,173 |
| 2021-09-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,764 | 7.60 | 13,402 |
| 2021-08-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 154 | 7.54 | 1,161 |
| 2021-08-02 | Hunt Douglas M (See Remarks) | Sale | 420 | 7.53 | 3,160 |
| 2021-08-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,764 | 7.53 | 13,286 |
| 2021-07-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 155 | 9.26 | 1,435 |
| 2021-07-02 | Hunt Douglas M (See Remarks) | Sale | 1,016 | 9.15 | 9,297 |
| 2021-07-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 5,332 | 8.84 | 47,118 |
| 2021-06-11 | Senderowicz Adrian (Director) | Sale | 40,993 | 11.17 | 457,768 |
| 2021-06-10 | Miller Ann Calby (Director) | Sale | 12,874 | 11.43 | 147,162 |
| 2021-06-10 | Wilson Troy Edward (Director) | Sale | 25,748 | 11.36 | 292,445 |
| 2021-06-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,757 | 10.74 | 18,877 |
| 2021-05-03 | Nougues Maximo F (Chief Financial Officer) | Sale | 152 | 9.91 | 1,506 |
| 2021-05-03 | Hunt Douglas M (See Remarks) | Sale | 417 | 9.91 | 4,132 |
| 2021-05-03 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,758 | 9.01 | 15,846 |
| 2021-04-05 | Nougues Maximo F (Chief Financial Officer) | Sale | 155 | 9.80 | 1,519 |
| 2021-04-05 | Hunt Douglas M (See Remarks) | Sale | 426 | 9.80 | 4,176 |
| 2021-04-05 | Bryce Richard Paul (SEE REMARKS) | Sale | 426 | 9.80 | 4,176 |
| 2021-04-05 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,584 | 9.80 | 15,527 |
| 2021-03-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 154 | 10.14 | 1,560 |
| 2021-03-02 | Hunt Douglas M (See Remarks) | Sale | 422 | 10.16 | 4,288 |
| 2021-03-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 422 | 10.15 | 4,283 |
| 2021-03-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,238 | 10.14 | 12,555 |
| 2021-02-02 | Nougues Maximo F (Chief Financial Officer) | Sale | 179 | 12.26 | 2,194 |
| 2021-02-02 | Hunt Douglas M (See Remarks) | Sale | 412 | 12.27 | 5,053 |
| 2021-02-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 415 | 12.23 | 5,075 |
| 2021-02-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 1,222 | 12.22 | 14,930 |
| 2021-01-04 | Nougues Maximo F (Chief Financial Officer) | Sale | 2,145 | 10.22 | 21,930 |
| 2021-01-04 | Hunt Douglas M (See Remarks) | Sale | 6,463 | 10.23 | 66,142 |
| 2021-01-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 6,548 | 10.23 | 67,018 |
| 2021-01-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 18,235 | 10.22 | 186,379 |
| 2020-12-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 92 | 11.65 | 1,071 |
| 2020-12-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 355 | 11.66 | 4,137 |
| 2020-11-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 97 | 7.81 | 757 |
| 2020-11-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 371 | 7.82 | 2,899 |
| 2020-10-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 91 | 10.14 | 923 |
| 2020-10-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 350 | 10.13 | 3,544 |
| 2020-09-16 | Moyes Jay M (Director) | Sale | 9,703 | 10.00 | 97,030 |
| 2020-09-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 90 | 9.77 | 879 |
| 2020-09-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 347 | 9.78 | 3,393 |
| 2020-08-03 | Bryce Richard Paul (SEE REMARKS) | Sale | 86 | 10.80 | 928 |
| 2020-08-03 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 330 | 10.79 | 3,560 |
| 2020-07-02 | Hunt Douglas M (See Remarks) | Sale | 572 | 10.69 | 6,111 |
| 2020-07-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 660 | 10.67 | 7,040 |
| 2020-07-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 2,607 | 10.66 | 27,803 |
| 2020-06-16 | Moyes Jay M (Director) | Sale | 9,720 | 9.50 | 92,340 |
| 2020-06-11 | Senderowicz Adrian (Director) | Sale | 10,000 | 9.89 | 98,880 |
| 2020-06-11 | Wilson Troy Edward (Director) | Sale | 25,245 | 9.97 | 251,692 |
| 2020-06-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 89 | 10.66 | 948 |
| 2020-06-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 342 | 10.71 | 3,661 |
| 2020-05-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 89 | 9.62 | 856 |
| 2020-05-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 339 | 9.70 | 3,288 |
| 2020-04-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 91 | 7.37 | 670 |
| 2020-04-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 347 | 7.38 | 2,562 |
| 2020-03-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 96 | 10.02 | 962 |
| 2020-03-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 372 | 10.02 | 3,725 |
| 2020-02-27 | Hunt Douglas M (See Remarks) | Sale | 1,728 | 10.25 | 17,717 |
| 2020-02-03 | Bryce Richard Paul (SEE REMARKS) | Sale | 105 | 8.02 | 841 |
| 2020-02-03 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 331 | 8.02 | 2,652 |
| 2020-01-02 | Hunt Douglas M (See Remarks) | Sale | 1,405 | 8.43 | 11,846 |
| 2020-01-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 1,516 | 8.38 | 12,704 |
| 2020-01-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 6,016 | 8.36 | 50,263 |
| 2019-12-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 83 | 10.34 | 858 |
| 2019-12-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 455 | 10.33 | 4,699 |
| 2019-11-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 88 | 7.38 | 649 |
| 2019-11-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 478 | 7.40 | 3,537 |
| 2019-10-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 91 | 10.05 | 914 |
| 2019-10-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 504 | 9.97 | 5,027 |
| 2019-09-12 | Hunt Douglas M (See Remarks) | Sale | 1,711 | 11.42 | 19,539 |
| 2019-09-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 95 | 10.11 | 960 |
| 2019-09-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 524 | 10.14 | 5,313 |
| 2019-08-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 94 | 9.00 | 846 |
| 2019-08-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 517 | 9.02 | 4,663 |
| 2019-07-22 | Bryce Richard Paul (SEE REMARKS) | Sale | 1,841 | 10.10 | 18,588 |
| 2019-07-22 | Lo Steven (Chief Commercial Officer) | Sale | 1,852 | 10.04 | 18,599 |
| 2019-07-22 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 12,715 | 9.98 | 126,844 |
| 2019-07-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 89 | 12.78 | 1,137 |
| 2019-07-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 495 | 12.78 | 6,326 |
| 2019-06-03 | Bryce Richard Paul (SEE REMARKS) | Sale | 88 | 15.07 | 1,326 |
| 2019-06-03 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 483 | 15.18 | 7,331 |
| 2019-05-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 85 | 32.38 | 2,752 |
| 2019-05-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 477 | 32.38 | 15,445 |
| 2019-04-02 | Bryce Richard Paul (SEE REMARKS) | Sale | 88 | 35.78 | 3,148 |
| 2019-04-02 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 491 | 35.79 | 17,572 |
| 2019-03-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 88 | 38.66 | 3,402 |
| 2019-03-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 496 | 38.62 | 19,155 |
| 2019-02-04 | Bryce Richard Paul (SEE REMARKS) | Sale | 89 | 27.77 | 2,471 |
| 2019-02-04 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 345 | 27.80 | 9,591 |
| 2019-02-04 | Eyler Charles R (SEE REMARKS) | Sale | 87 | 27.64 | 2,404 |
| 2019-01-22 | Bryce Richard Paul (SEE REMARKS) | Sale | 1,959 | 24.72 | 48,426 |
| 2019-01-22 | Lo Steven (Chief Commercial Officer) | Sale | 2,114 | 24.91 | 52,663 |
| 2019-01-22 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 8,825 | 24.74 | 218,330 |
| 2019-01-22 | Eyler Charles R (SEE REMARKS) | Sale | 713 | 24.80 | 17,682 |
| 2019-01-03 | Bryce Richard Paul (SEE REMARKS) | Sale | 1,210 | 20.67 | 25,010 |
| 2019-01-03 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 4,424 | 20.67 | 91,444 |
| 2019-01-03 | Eyler Charles R (SEE REMARKS) | Sale | 1,210 | 20.67 | 25,010 |
| 2018-12-03 | Eyler Charles R (SEE REMARKS) | Sale | 1,239 | 22.77 | 28,212 |
| 2018-07-20 | Bryce Richard Paul (SEE REMARKS) | Sale | 1,836 | 51.95 | 95,382 |
| 2018-07-20 | Lo Steven (Chief Commercial Officer) | Sale | 1,839 | 51.85 | 95,359 |
| 2018-07-20 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 12,520 | 52.00 | 651,014 |
| 2018-07-20 | Eyler Charles R (SEE REMARKS) | Sale | 610 | 51.95 | 31,689 |
| 2018-06-01 | Eyler Charles R (SEE REMARKS) | Sale | 1,211 | 53.00 | 64,183 |
| 2018-01-22 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 1,860 | 92.75 | 172,515 |
| 2018-01-22 | Lo Steven (Chief Commercial Officer) | Sale | 1,858 | 92.85 | 172,515 |
| 2018-01-22 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 10,692 | 92.75 | 991,683 |
| 2018-01-22 | Eyler Charles R (SEE REMARKS) | Sale | 669 | 92.85 | 62,116 |
| 2017-12-01 | Eyler Charles R (SEE REMARKS) | Sale | 1,322 | 105.47 | 139,424 |
| 2017-09-29 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 15,000 | 120.00 | 1,800,000 |
| 2017-09-29 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Option Ex | 15,000 | 11.30 | 169,500 |
| 2017-09-07 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 14,000 | 100.10 | 1,401,400 |
| 2017-09-07 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Option Ex | 14,000 | 11.30 | 158,200 |
| 2017-09-06 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 1,000 | 100.00 | 100,000 |
| 2017-09-06 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Option Ex | 1,000 | 11.30 | 11,300 |
| 2017-07-20 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 1,998 | 94.84 | 189,490 |
| 2017-07-20 | Lo Steven (Chief Commercial Officer) | Sale | 1,990 | 94.90 | 188,852 |
| 2017-07-20 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 13,175 | 94.97 | 1,251,256 |
| 2017-07-20 | Eyler Charles R (SEE REMARKS) | Sale | 662 | 95.15 | 62,991 |
| 2017-07-03 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 5,000 | 87.10 | 435,500 |
| 2017-07-03 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Option Ex | 5,000 | 11.30 | 56,500 |
| 2017-06-12 | Gross Phillip | Sale | 88,944 | 79.64 | 7,083,144 |
| 2017-06-09 | Gross Phillip | Sale | 58,316 | 80.85 | 4,714,848 |
| 2017-06-08 | Gross Phillip | Sale | 100,000 | 81.19 | 8,118,800 |
| 2017-06-05 | Gross Phillip | Sale | 307,128 | 91.81 | 28,197,114 |
| 2017-06-02 | Gross Phillip | Sale | 30,475 | 83.06 | 2,531,283 |
| 2017-06-01 | Gross Phillip | Sale | 169,525 | 82.98 | 14,066,845 |
| 2017-05-26 | Gross Phillip | Sale | 300,000 | 77.58 | 23,273,400 |
| 2017-05-25 | Gross Phillip | Sale | 400,000 | 78.12 | 31,246,800 |
| 2017-05-24 | Gross Phillip | Sale | 535,700 | 71.78 | 38,450,403 |
| 2017-02-01 | Charnas Robert (Other) | Sale | 3,008 | 31.82 | 95,729 |
| 2017-01-20 | Charnas Robert (Other) | Sale | 2,293 | 33.23 | 76,207 |
| 2017-01-20 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 2,293 | 33.23 | 76,207 |
| 2017-01-20 | Lo Steven (Chief Commercial Officer) | Sale | 2,290 | 33.23 | 76,108 |
| 2017-01-20 | Auerbach Alan H (PRESIDENT AND CEO) | Sale | 10,202 | 33.23 | 339,063 |
| 2017-01-20 | Eyler Charles R (SEE REMARKS) | Sale | 820 | 33.23 | 27,252 |
| 2015-07-06 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Sale | 3,000 | 110.03 | 330,084 |
| 2015-07-06 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Option Ex | 3,000 | 11.30 | 33,900 |
| 2014-04-11 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Buy | 28 | 82.49 | 2,309 |
| 2014-04-09 | Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV) | Buy | 2 | 87.35 | 174 |
Insider trading activities including stock purchases, stock sales, and option exercises of PBYI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Puma Biotechnology, Inc. (symbol PBYI, CIK number 1401667) see the Securities and Exchange Commission (SEC) website.